The bet was never small, even if the movie was. Clayface is the third film in James Gunn and Peter Safran's DC Universe, the first one built as straight horror — R-rated body horror about Matt Hagen, a disfigured actor (Tom Rhys Harries) who becomes the thing in the title — written by Mike Flanagan, the genre's most trusted name, and Hossein Amini, and directed by Speak No Evil's James Watkins. After Supergirl's rough summer, DC needed this modestly priced monster movie to work.
On the Friday numbers, it works. Deadline's estimates put Clayface at $9.5 million for Friday (including $3.5 million from previews) on its way to a $23–25 million No. 1 weekend — and the grades underneath the grosses are the real headline. An A− CinemaScore is something horror films almost never get; opening-night audiences usually grade the genre on a curve that starts at B. PostTrak had it at four and a half stars, and the Rotten Tomatoes audience score sits at 94%. Gunn has been saying for a year that there's "not a company style" at DC Studios. This weekend is the first receipt.
And yet the box-office story with the longest shadow is playing down the hall. You Can See Everything, A24's Elizabeth Holmes documentary from Nathan Fielder and Lance Oppenheim, opened last weekend in 855 theaters and made $15.6 million — the biggest debut for a nonmusical documentary in two decades, per Deadline. Do the per-screen math: the Holmes film averaged roughly $18,000 a theater. Clayface, on its current estimate, is tracking near $7,000. One of those numbers is three times the other, and it isn't the superhero movie's.
This weekend the doc stops being a curiosity and becomes a direct competitor: it expands to around 2,600 theaters, with estimates near $19 million for its second frame. Holmes — Theranos, the black turtlenecks, the voice — remains, nearly a decade after the fraud unraveled, a figure audiences will pay to stare at. Fielder and Oppenheim built the film out of that staring, and the market is answering.
So the weekend shapes up as fall's cleanest culture fight: the studio system's cheapest, strangest swing versus a documentary about America's most infamous founder, both winning at once. The honest asterisk, and it matters: these are Friday estimates, not finals — the weekend's official numbers land Sunday and Monday, and this story will be updated with them. But the shape is already clear. Horror took the crown. The documentary took the per-screen crown, the expansion, and the conversation — and Elizabeth Holmes, somehow, is a box-office draw again.
Read our review: ‘Clayface’ Review: DC’s Body-Horror Gamble Mostly Pays Off — our critics on the film itself.
By the Numbers
Sources · 3 sources
- Deadline box-office reporting (Friday estimates), carried Oct 24 by ComicBasics and TheHorrorFeed: Clayface's $9.5M Friday, $3.5M previews, $23–25M weekend projection, 3,458 theaters, A− CinemaScore, PostTrak 4½ stars; the Holmes documentary's $15.6M debut from 855 theaters (largest for a nonmusical doc in 20 years) and its ~2,600-theater, ~$19M second-weekend expansion.
- Warner Bros. / DC Studios (official site and press materials) — Clayface credits: dir. James Watkins; writers Mike Flanagan, Hossein Amini; Tom Rhys Harries, Naomi Ackie, Max Minghella, Eddie Marsan; opened Oct 23.
- James Gunn on the film's horror identity ("a complete horror film… there's not a company style") — CBS Mornings, via The Nerd Wire's cast/release briefing.
